Results 41 to 50 of about 3,285 (205)

Plasmodium falciparum multidrug resistance gene-1 polymorphisms in Northern Nigeria: implications for the continued use of artemether-lumefantrine in the region

open access: yesMalaria Journal, 2020
Background The analysis of single nucleotide polymorphism (SNPs) in drug-resistance associated genes is a commonly used strategy for the surveillance of anti-malarial drug resistance in populations of parasites.
Auwal Adamu   +11 more
doaj   +1 more source

Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2

open access: yesChemMedChem, Volume 17, Issue 22, November 18, 2022., 2022
Toolkit expansion: We report an exploration of the antimalarial compound MMV692140. The mode of resistance was identified as PfeEF2. The structural motif was explored in a chemistry program, resulting in the identification of MMV1919557, an analog with significantly improved antimalarial potency.
Benoît Laleu   +19 more
wiley   +1 more source

Efficacy of Artemether-Lumefantrine in Treatment of Malaria Among Under-Fives and Prevalence of Drug Resistance Markers in Igombe-Mwanza, North-Western Tanzania. [PDF]

open access: yes, 2012
\ud \ud Drug resistance to anti-malarials is a major public health problem worldwide. This study aimed at establishing the efficacy of artemether-lumefantrine (ACT) in Igombe-Mwanza, north-western Tanzania after a few years of ACT use, and establish the ...
Kamugisha, Erasmus   +20 more
core   +1 more source

Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs. [PDF]

open access: yes, 2007
Parasite drug resistance is partly conferred by single-nucleotide polymorphisms (SNPs), and monitoring them has been proposed as an alternative to monitoring drug resistance.
Regös, Attila   +27 more
core   +1 more source

Characterization of lumefantrine, mefloquine, and chloroquine transport via PfMDR1.

open access: yes, 2022
(a–c) There were significant differences in the apparent kinetic parameters of lumefantrine (a), mefloquine (b), and chloroquine (c) transport between field isoforms of PfMDR1. The concentration dependence of PfMDR1-mediated drug transport was calculated
Ben Corry (135521)   +3 more
core   +1 more source

Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015

open access: yesMalaria Journal, 2018
Background Artemisinin-based combination therapy is the first-line anti-malarial treatment for uncomplicated Plasmodium falciparum infection in Angola.
Dragan Ljolje   +12 more
doaj   +1 more source

Distribution of pfmdr1 polymorphisms in Plasmodium falciparum isolated from Southern Thailand [PDF]

open access: yesMalaria Journal, 2014
تعتبر مقاومة الأدوية في المتصورة المنجلية مشكلة رئيسية في مكافحة الملاريا خاصة على طول الحدود التايلاندية- الميانمارية والتايلاندية- الكمبودية. حتى الآن، تم تحديد عدد قليل من العلامات الجزيئية لمقاومة الملاريا في P. falciparum، بما في ذلك ناقل مقاومة الكلوروكين P. falciparum (pfcrt) ومقاومة الأدوية المتعددة P. falciparum 1 (pfmdr1).
Mathirut Mungthin   +7 more
openaire   +2 more sources

Rates of PfMDR1-mediated drug transport.

open access: yes, 2022
PfMDR1, Plasmodium falciparum multidrug resistance protein 1. (XLSX)
Ben Corry (135521)   +3 more
core   +1 more source

Predicted topologies of PfMDR1 and PfCRT.

open access: yes, 2022
(a) PfMDR1 consists of 1,419 amino acid residues that are arranged into 12 TMDs and 2 NBDs. The length of the loops shown surrounding the NBDs are approximate. (b) PfCRT consists of 424 amino acid residues that are arranged into 10 TMDs.
Ben Corry (135521)   +3 more
core   +1 more source

PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers [PDF]

open access: yesScientific Reports, 2016
AbstractTreatment of the symptomatic asexual stage of Plasmodium falciparum relies almost exclusively on artemisinin (ART) combination therapies (ACTs) in endemic regions. ACTs combine ART or its derivative with a long-acting partner drug to maximize efficacy during the typical three-day regimen.
Richard T. Eastman   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy